InsidersTradesSigma
Follow the HEM파마 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, HEM파마 has logged 0 public disclosures. Market capitalisation: €286.3bn. Every trade is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
No declarations found
0 of 0 declarations
HEM파마 is a company in the health and pharmaceutical sector, listed on the XKRX market. It specializes in the development and marketing of pharmaceutical products.